Kadimastem Company Description

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases.

Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes.

The company was incorporated in 2008 and is based in Ness Ziona, Israel.

Kadimastem Ltd

Country	Israel
Founded	2008
Industry	Biotechnology
Sector	Healthcare
Employees	12
CEO	Ronen Twito

Contact Details

Address: Pinchas Sapir 7 Ness Ziona, 74140 Israel
Phone	972 73 797 1600
Website	kadimastem.com

Stock Details

Ticker Symbol	KDST
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	ILS
ISIN Number	IL0011284614
SIC Code	2836

Key Executives

Name	Position
Uri Ben-Or	Chief Financial Officer
Prof. Michel Revel M.D., Ph.D.	Co-Founder, Chief Scientist, Head of the Scientific Advisory Board and Director
Yossi Ben-Yossef	Honorary President and Strategic Consultant
Olivier Samuel	Vice President of European Business Development and Director